Medicinal chemistry and the discovery process 药物化学与药物发现流程
本节覆盖 slides 6–9A discipline at the intersection of chemistry and pharmacology, involved with designing, synthesizing and developing pharmaceutical drugs. It also studies existing drugs, their biological properties, and quantitative structure-activity relationships (QSAR). p.6 药物化学是处于化学与药理学交叉点的学科,从事药物的设计、合成与开发。它也研究已有药物、其生物学性质以及定量构效关系(QSAR)。
Core stages: discovery (hit-to-lead and lead optimization), synthetic chemistry and structural analysis, then development. Hit-to-lead and lead optimization are the chemistry-driven front end of the pipeline. p.7 核心阶段:发现(从苗头到先导 hit-to-lead 及先导优化)、合成化学与结构分析,随后进入开发。从苗头到先导及先导优化是流程中由化学驱动的前端环节。
1) Select disease — choose a disease area prioritizing unmet medical need. 2) Identify targets — pinpoint proteins, enzymes or DNA involved in the molecular mechanism. p.8 1)选择疾病:聚焦存在未满足医疗需求的疾病领域。2)确定靶点:定位参与分子机制的蛋白、酶或 DNA。
3) Synthesize ligands — design novel small molecules that selectively bind the target with high affinity and specificity. 4) Assess function — test activity, efficacy and safety in vitro and in vivo. p.8 3)合成配体:设计能以高亲和力和特异性选择性结合靶点的新型小分子。4)评估功能:通过体外和体内实验测试活性、疗效与安全性。
Disease level: epidemiology (distribution, prevalence, risk factors) plus causes and pathology (etiology and tissue alterations). System/cell level: mechanisms driving disease, molecular signaling pathways and immune responses. p.9 疾病层面:流行病学(分布、患病率、风险因素)以及病因与病理(病原学和组织改变)。系统/细胞层面:驱动疾病的机制、分子信号通路与免疫应答。
Molecular target level: the molecule's cellular role and the key binding (therapeutic) sites for drug development. p.9 分子靶点层面:分子在细胞中的作用,以及药物开发的关键结合(治疗)位点。
Generated by GPT-Image-2.6 Sunburst